Creative Biolabs Expands Advanced Single-Cell Multi-Omics and RNA Sequencing Solutions to Support Biomedical Discovery

SHIRLEY, NY, September 09, 2026 /24-7PressRelease/ — Designed to meet the escalating demand for high-resolution cellular profiling, the upgraded suite offers end-to-end services ranging from single-cell transcriptome profiling to integrated multimodal and multi-omics workflows, empowering global researchers across oncology, immunology, and neuroscience.

As life science research increasingly transitions from bulk tissue profiling to single-cell resolution, dissecting cellular heterogeneity has become essential for identifying rare cell subpopulations, characterizing complex tumor microenvironments, and tracing cell lineage trajectories. To support these critical pipelines, Creative Biolabs delivers robust, high-throughput single-cell RNA sequencing services that offer high sensitivity and coverage across thousands of individual cells, delivering high-resolution transcriptomic insights from diverse fresh biological specimens.

Addressing the long-standing laboratory challenge of processing complex, fibrous, or biobanked archival samples, the platform also features specialized single-nucleus RNA sequencing (snRNA-seq) capabilities. For tissues where single-cell dissociation is prone to cell damage, dissociation-induced stress responses, or selective loss of fragile cell types—such as human brain, myocardium, or flash-frozen clinical biopsies—Creative Biolabs provides an optimized single-cell nuclei RNA sequencing service. By isolating intact nuclei, this approach bypasses harsh enzymatic dissociation while minimizing dissociation-related artifacts while retaining informative nuclear RNA profiles, dramatically expanding the scope of clinical translational research.

Recognizing that cellular identity is orchestrated across multiple regulatory layers, Creative Biolabs goes beyond single-dimensional analysis by advancing its high-throughput single-cell multi-omics service. This integrated platform allows the simultaneous interrogation of genomic variations, epigenomic landscapes (e.g., chromatin accessibility), cell surface proteomics (CITE-seq), and transcriptomes within identical single cells. By directly linking epigenetic regulation and genomic alterations to gene expression readouts, the service enables researchers to construct multi-dimensional cellular atlases and uncover novel therapeutic targets with unprecedented biological clarity.

“Understanding biology at single-cell and single-nucleus resolution is no longer a luxury—it is fundamental to precision medicine and biomarker discovery,” said a senior scientist at Creative Biolabs. “Our goal is to provide researchers with a seamless, modular analytical ecosystem that transforms difficult biological samples into reliable, high-dimensional datasets with rigorous bioinformatics support.”

Supported by advanced microfluidics technologies, stringent quality control benchmarks, and tailored bioinformatics pipelines, Creative Biolabs continues to partner with academic and biopharmaceutical research teams worldwide to unravel the complexities of human disease.

For more information about Creative Biolabs and its full suite of single-cell analytical solutions, please visit https://singlecell.creative-biolabs.com/.

About Creative Biolabs
Creative Biolabs is a biotechnology service provider dedicated to providing cutting-edge single-cell technologies, next-generation sequencing, and comprehensive multi-omics solutions. With deep domain expertise and state-of-the-art platforms, Creative Biolabs supports discovery programs in target validation, immunology profiling, and translational drug development.

—
For the original version of this press release, please visit 24-7PressRelease.com here